GENWORTH FINANCIAL INC Q4 FY2024 earnings call

• 2024 marked the 20th anniversary of Genworth's IPO. Achievements included progress on MYRAP with 87% of projected value achieved, debt reduction, and share repurchase program. - CareScout made progress in 2024 with 86% coverage of the 65-plus census population and nearly 500 providers. - Fourth quarter results: net loss of $1 million, adjusted operating income of $15 million led by Enact. Full year results: net income of $299 million, adjusted operating income of $273 million led by Enact. - Discussed financial performance of U.S. life insurance companies, including fourth quarter loss and full year statutory income. - Outlined three strategic priorities: creating shareholder value via Enact, maintaining self-sustainability of legacy LTC business, and driving growth via CareScout. - Details on CareScout Quality Network coverage and provider growth. - Progress on CareScout Insurance, including product filings and plan to launch new product, plan to invest $75 million in new insurer, and reinsurance arrangement. - MYRAP progress with over 58% of policyholders choosing benefit reductions, $3.2 billion net present value growth in 2024. - Annual assumption reviews impact on LTC and life annuity businesses. - Investment portfolio and liquidity: holding company cash and liquid assets of $294 million, share repurchase and debt reduction in 2024.

For the fourth quarter, Genworth reported a net loss of $1 million. Adjusted operating income was $15 million, led by Enact's strong performance contributing $137 million. For the full year, net income was $299 million or $0.68 per share with adjusted operating income of $273 million. Enact contributed $585 million to adjusted operating income for the full year. The U.S. life insurance companies had an estimated pretax statutory loss of $33 million in the fourth quarter and $378 million pretax statutory income for the full year. Enact's fourth quarter adjusted operating income was $137 million, a 6% year-over-year increase. The LTC segment had an adjusted operating loss of $104 million in the fourth quarter and $176 million for the full year. Life and Annuities had adjusted operating income of $5 million in the fourth quarter and a $38 million loss for the full year. Corporate and Other had a $23 million loss in the fourth quarter and a $98 million loss for the full year.

• Enact expected to return similar capital levels in 2025 as in 2024. - Plan to invest $45 million to $50 million in CareScout Services in 2025. - Intend to allocate $100 million to $120 million for share repurchases in 2025. - Retired $66 million of principal debt in 2024, holding company debt at $790 million. - Plan to launch CareScout's first new insurance product in 2025. - Plan to invest $75 million in the new CareScout Insurance Company later in 2025.

• Forward-looking statements may differ materially from actual results,需参考SEC文件风险因素。- Annual assumption reviews had unfavorable impacts on LTC and life annuity businesses. - Uncertainty of U.K. court case. - Risks in launching new CareScout Insurance product including regulation and risk management.

Q: Give more color on how CareScout Services revenue will emerge, and if to start generating revenues in 2025.

A: Samir Shah explained that CareScout makes revenue by negotiating discounts with network providers and sharing part of the rate reduction with insurer and policyholder, already has revenue from assessment business, and details on revenue based on care type, claim length.

Q: Update on timing of U.K. court case.

A: The court case between AXA and Santander is scheduled for early March, and if it goes to trial without settlement, would be about 6 weeks.

Q: Will fund the $75 million capital contribution into the new CareScout Insurance entity from existing holding company resources.

A: Jerome Upton said there is a strong base operating plan from a cash flow perspective and the $75 million is included in the base plan and funded from existing holding company resources